Skip to main content
Erschienen in: Acta Diabetologica 2/2023

09.11.2022 | Original Article

Bariatric surgery normalizes diabetes risk index by one month post-operation

verfasst von: Vincent J. Sinatra, BingXue Lin, Manish Parikh, Jeffrey S. Berger, Edward A. Fisher, Sean P. Heffron

Erschienen in: Acta Diabetologica | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Aim

The Diabetes risk index (DRI) is a composite of NMR-measured lipoproteins and branched chain amino acids predictive of diabetes mellitus development. Bariatric surgery is indicated in patients with severe obesity, many of whom are at high-risk for developing diabetes. Substantial weight loss occurs following bariatric surgery and sustained weight loss likely contributes to reductions in the development of diabetes and cardiovascular disease. However, some evidence suggests that bariatric surgical procedures themselves may contribute to reducing risk of these conditions independent of weight loss. We aimed to investigate DRI and its association with reductions in body weight and adiposity over one year following bariatric surgery.

Methods

We examined 51 severely obese premenopausal women without diabetes. DRI, BMI, body weight and waist measurements were made before and at 1, 6 and 12 months after Roux-en-Y Gastric Bypass (RYGB) or Sleeve Gastrectomy. Values were compared to healthy women with normal BMI (18.5–24.9 kg/m2; n = 15).

Results

Non-diabetic women with severe obesity (BMI 44.7 ± 6.2 kg/m2) exhibited significantly elevated DRI scores prior to surgery versus controls (35 [26, 39] vs 12 [1, 20]; p < 0.0001). At 1 month after surgery, BMI decreased 5.1 ± 1.1 kg/m2, but DRI decreased so that it no longer differed from that of normal BMI controls (1.9 [1, 17] vs control 12 [1, 20]; p = 0.35). Subjects continued to lose weight, whereas DRI remained similar, throughout follow-up with DRI 1.0 [1, 7] at 12 months. Changes in DRI did not correlate with changes in BMI, body weight or waist circumference at any time during follow-up. There was no difference in change in DRI between surgical procedures or pre-operative metabolic syndrome status.

Conclusions

Our analysis of DRI scores supports the capacity of bariatric surgery to reduce risk of developing diabetes in severely obese individuals. Our findings suggest that bariatric surgical techniques may have inherent effects that improve cardiometabolic risk independent of reductions in body weight or adiposity.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
5.
Zurück zum Zitat Samuel VT, Shulman GI (2016) The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Investig 126(1):12–22CrossRef Samuel VT, Shulman GI (2016) The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Investig 126(1):12–22CrossRef
6.
Zurück zum Zitat Lillioja S, Mott DM, Spraul M et al (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus prospective studies of pima indians. N Eng J Med 329(27):1988–1992CrossRef Lillioja S, Mott DM, Spraul M et al (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus prospective studies of pima indians. N Eng J Med 329(27):1988–1992CrossRef
9.
Zurück zum Zitat National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).(2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 106(25), 3143–421 National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).(2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 106(25), 3143–421
10.
Zurück zum Zitat Rerksuppaphol S, Berksuppaphol L (2015) Metabolic syndrome in obese thai children: defined using modified the national cholesterol education program/adult treatment panel III criteria. J Med Assoc Thai 98(Suppl_10):S88–S95 Rerksuppaphol S, Berksuppaphol L (2015) Metabolic syndrome in obese thai children: defined using modified the national cholesterol education program/adult treatment panel III criteria. J Med Assoc Thai 98(Suppl_10):S88–S95
12.
Zurück zum Zitat American diabetes association classification and diagnosis of diabetes (2017) In standards of medical care in diabetes—2017. Diabetes Care 40(Suppl 1):S11–S24 American diabetes association classification and diagnosis of diabetes (2017) In standards of medical care in diabetes—2017. Diabetes Care 40(Suppl 1):S11–S24
14.
Zurück zum Zitat Lee JM, Gebremariam A, Wu EL, LaRose J, Gurney JG (2011) Evaluation of nonfasting tests to screen for childhood and adolescent dysglycemia. Diabetes Care 34:2597–2602CrossRef Lee JM, Gebremariam A, Wu EL, LaRose J, Gurney JG (2011) Evaluation of nonfasting tests to screen for childhood and adolescent dysglycemia. Diabetes Care 34:2597–2602CrossRef
16.
Zurück zum Zitat Khokar A et al (2017) Comparison of a1c to oral glucose tolerance test for diagnosis of prediabetes in overweight and obese youth. Clin Diabetes 35(3):133–140CrossRef Khokar A et al (2017) Comparison of a1c to oral glucose tolerance test for diagnosis of prediabetes in overweight and obese youth. Clin Diabetes 35(3):133–140CrossRef
17.
Zurück zum Zitat Yamada C et al (2011) Optimal reference interval for homeostasis model assessment of insulin resistance in a Japanese population. J Diabetes Investig 2(5):373–376CrossRef Yamada C et al (2011) Optimal reference interval for homeostasis model assessment of insulin resistance in a Japanese population. J Diabetes Investig 2(5):373–376CrossRef
19.
Zurück zum Zitat Ferrannini E et al (2005) β-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab 90(1):493–500CrossRef Ferrannini E et al (2005) β-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab 90(1):493–500CrossRef
20.
Zurück zum Zitat Abdul-Ghani MA et al (2008) The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance. Am J Physiol Endocrinol Metab 295(2):E401–E406CrossRef Abdul-Ghani MA et al (2008) The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance. Am J Physiol Endocrinol Metab 295(2):E401–E406CrossRef
21.
Zurück zum Zitat Mackey RH, Mora S, Bertoni AG et al (2015) Lipoprotein particles and incident type 2 diabetes in the multi-ethnic study of atherosclerosis. Diabetes Care 38(4):628–636CrossRef Mackey RH, Mora S, Bertoni AG et al (2015) Lipoprotein particles and incident type 2 diabetes in the multi-ethnic study of atherosclerosis. Diabetes Care 38(4):628–636CrossRef
22.
Zurück zum Zitat Flores-Guerrero JL, Connelly MA, Shalaurova I et al (2019) Lipoprotein insulin resistance index, a high-throughput measure of insulin resistance, is associated with incident type ii diabetes mellitus in the prevention of renal and vascular end-stage disease study. J Clin Lipidol 13(1):129–137CrossRef Flores-Guerrero JL, Connelly MA, Shalaurova I et al (2019) Lipoprotein insulin resistance index, a high-throughput measure of insulin resistance, is associated with incident type ii diabetes mellitus in the prevention of renal and vascular end-stage disease study. J Clin Lipidol 13(1):129–137CrossRef
23.
Zurück zum Zitat Flores-Guerrero JL, Gruppen EG, Connelly MA et al (2020) A newly developed diabetes risk index, based on lipoprotein subfractions and branched chain amino acids, is associated with incident type 2 diabetes mellitus in the prevend cohort. J Clin Med 9(9):2781. https://doi.org/10.3390/jcm9092781CrossRef Flores-Guerrero JL, Gruppen EG, Connelly MA et al (2020) A newly developed diabetes risk index, based on lipoprotein subfractions and branched chain amino acids, is associated with incident type 2 diabetes mellitus in the prevend cohort. J Clin Med 9(9):2781. https://​doi.​org/​10.​3390/​jcm9092781CrossRef
24.
Zurück zum Zitat DeFronzo RA, Abdul-Ghani MA (2011) Preservation of β-cell function: the key to diabetes prevention. J Clin Endocrinol Metab 96(8):2354–2366CrossRef DeFronzo RA, Abdul-Ghani MA (2011) Preservation of β-cell function: the key to diabetes prevention. J Clin Endocrinol Metab 96(8):2354–2366CrossRef
25.
Zurück zum Zitat DeFronzo RA (2009) Banting lecture from the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58(4):773–795CrossRef DeFronzo RA (2009) Banting lecture from the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58(4):773–795CrossRef
27.
Zurück zum Zitat Alberti KGM, Zimmet P, Shaw J (2005) The metabolic syndrome—a new worldwide definition a consensus statement from the international diabetes federation. Lancet 366(9491):1059–1062CrossRef Alberti KGM, Zimmet P, Shaw J (2005) The metabolic syndrome—a new worldwide definition a consensus statement from the international diabetes federation. Lancet 366(9491):1059–1062CrossRef
28.
Zurück zum Zitat Ginsberg HN, Zhang Y, Hernandez Ono A (2005) Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res 36(3):232–240CrossRef Ginsberg HN, Zhang Y, Hernandez Ono A (2005) Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res 36(3):232–240CrossRef
29.
Zurück zum Zitat Lewis GF, Carpentier A, Adeli K, Giacca A (2002) Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 23(2):201–229CrossRef Lewis GF, Carpentier A, Adeli K, Giacca A (2002) Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 23(2):201–229CrossRef
31.
35.
Zurück zum Zitat Flores-Guerrero JL, Osté MCJ, Kieneker LM et al (2018) Plasma branched-chain amino acids and risk of incident type 2 diabetes: results from the prevend prospective cohort study. J Clin Med 7(12):513CrossRef Flores-Guerrero JL, Osté MCJ, Kieneker LM et al (2018) Plasma branched-chain amino acids and risk of incident type 2 diabetes: results from the prevend prospective cohort study. J Clin Med 7(12):513CrossRef
36.
Zurück zum Zitat Wolak-Dinsmore J, Gruppen EG, Shalaurova I et al (2018) A novel NMR-based assay to measure circulating concentrations of branched-chain amino acids: Elevation in subjects with type 2 diabetes mellitus and association with carotid intima media thickness. Clin Biochem 54:92–99CrossRef Wolak-Dinsmore J, Gruppen EG, Shalaurova I et al (2018) A novel NMR-based assay to measure circulating concentrations of branched-chain amino acids: Elevation in subjects with type 2 diabetes mellitus and association with carotid intima media thickness. Clin Biochem 54:92–99CrossRef
38.
Zurück zum Zitat Laferrere B, Reilly D, Arias S et al (2011) Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss. Sci Transl Med 3(80):80re2CrossRef Laferrere B, Reilly D, Arias S et al (2011) Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss. Sci Transl Med 3(80):80re2CrossRef
39.
Zurück zum Zitat Lips MA et al (2014) Roux-en-Y gastric bypass surgery but no calorie restriction reduces plasma branched-chain amino acids in obese women independent of weight loss or the presence of type 2 diabetes. Diabetes Care 37(12):3150–3156CrossRef Lips MA et al (2014) Roux-en-Y gastric bypass surgery but no calorie restriction reduces plasma branched-chain amino acids in obese women independent of weight loss or the presence of type 2 diabetes. Diabetes Care 37(12):3150–3156CrossRef
43.
Zurück zum Zitat Pories WJ (2004) Diabetes: the evolution of a new paradigm. Annal Surg 239(1):12–13CrossRef Pories WJ (2004) Diabetes: the evolution of a new paradigm. Annal Surg 239(1):12–13CrossRef
46.
Zurück zum Zitat Bojsen-Moller KN et al (2014) Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after roux-en-y gastric bypass. Diabetes 63(5):1725–1737. https://doi.org/10.2337/db13-1307CrossRef Bojsen-Moller KN et al (2014) Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after roux-en-y gastric bypass. Diabetes 63(5):1725–1737. https://​doi.​org/​10.​2337/​db13-1307CrossRef
48.
Metadaten
Titel
Bariatric surgery normalizes diabetes risk index by one month post-operation
verfasst von
Vincent J. Sinatra
BingXue Lin
Manish Parikh
Jeffrey S. Berger
Edward A. Fisher
Sean P. Heffron
Publikationsdatum
09.11.2022
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 2/2023
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-022-02002-x

Weitere Artikel der Ausgabe 2/2023

Acta Diabetologica 2/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.